Jong-Ho Cha

5PUBLICATIONS
33CO-AUTHORS
BiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 26, 2026
Bacteria-mimicking cancer cells reprogram macrophages via multiple pattern recognition receptor pathways for cancer immunotherapy.

|Apr 01, 2026
Therapy-induced senescent cancer cells as bidirectional regulators of antitumor immunity and resistance in the tumor microenvironment.

Minji Choi, Daeun Lee, Wen-Hao Yang

|Feb 11, 2025
Ribonuclease 1 Induces T-Cell Dysfunction and Impairs CD8+ T-Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1.

Wen-Hao Yang, Bao-Yue Huang, Hsing-Yu Rao

|Jan 03, 2025
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation.

Hyun Jung Hwang, Donghee Kang, Jisoo Shin

|May 14, 2021
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.

Heng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang

Pageof 1

Frequent Collaborators

4 joint publications

Wen-Hao Yang

2 joint publications

Shao-Chun Wang

2 joint publications

Mien-Chie Hung

1 joint publications

Heng-Huan Lee